Research Article
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
Figure 1
Ranolazine effect on Hb1Ac and short-term GV. (a) Patients with at baseline and 3 months in the two groups; (b) Patients with at baseline and 3 months in the two groups. Hb1Ac: haemoglobin 1Ac; TIR: time in range.
(a) |
(b) |